Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Stellar AfricaGold Inc Intersects Multiple Wide High-Grade Gold...

October 3, 2025

How AI is Poised to Rewire the Foundations...

June 7, 2025

Iris Secures Right to High-grade Tungsten Project, Montana...

December 18, 2025

Ignite Investment Summit Hong Kong Presentation

March 27, 2025

Blue Lagoon Completes Second Tranche of Private Placement...

March 18, 2025

Zijin to Take on Precious Metals Streaming as...

May 28, 2025

Strong Start to Maiden Drill Program at Oasis

August 27, 2025

Locksley Resources: High-grade Antimony & Rare Earths Prospects...

September 30, 2025

First patient dosed in Phase IIb imaging for...

April 28, 2025

Syntheia

July 4, 2025